Increased bacterial adherence and biomass in Pseudomonas aeruginosa bacteria exposed to clarithromycin

被引:14
作者
Garey, Kevin W. [1 ,2 ,3 ]
Vo, Quynh P.
Lewis, Russell E.
Saengcharoen, Woranuch [5 ]
LaRocco, Mark T. [4 ]
Tam, Vincent H. [2 ]
机构
[1] Univ Houston, Coll Pharm, Texas Med Ctr, Dept Clin Sci & Adm, Houston, TX 77030 USA
[2] St Lukes Episcopal Hosp, Dept Pharm, Houston, TX 77030 USA
[3] St Lukes Episcopal Hosp, Dept Infect Control, Houston, TX 77030 USA
[4] St Lukes Episcopal Hosp, Dept Pathol, Houston, TX 77030 USA
[5] Prince Songkla Univ, Dept Clin Pharm, Fac Pharmaceut Sci Hat Yai, Hat Yai 90112, Thailand
关键词
Biofilms; P; aeruginosa; Clarithromycin; Macrolides; MACROLIDE ANTIBIOTICS; BIOFILM FORMATION; GENE-EXPRESSION; AZITHROMYCIN;
D O I
10.1016/j.diagmicrobio.2008.09.007
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Long-term low-dose macrolides alter response in patients with chronic sessile Pseudomonas aeruginosa colonization. We examined the effect of clarithromycin on 1) adherence of P aeruginosa cells and 2) biofilm fort-nation. A suspended-coupon continuous-flow biofilm reactor model was used. Adherent P aeruginosa bacteria were established for 24 h, immediately followed by a 24-h continuous-flow operation (CFO) phase with serial sampling. In addition, the effect of clarithromycin oil adherent biomass was assessed quantitatively using a colorimetric assay. Isolates preexposed to clarithromycin were more adherent to the suspended coupons than nonexposed isolates (P = 0.021). After 2 h of CFO, a 1.30 +/- 0.86 log colony-forining unit (CFU)/cm(2) decrease was observed in controls compared with a 0.08 +/- 0.55 log CFU/cm(2) decrease in isolates exposed to clarithromycin. Furthermore, a concentration-dependent increase in biofilm biomass was observed with the addition of clarithromycin in a standard mucoid P aeruginosa strain (1-64 mu g/mL, P < 0.001) and 44 clinical P. aeruginosa strains (2 or 32 mu g/mL, P < 0.001). Clarithromycin increased bacterial adherence to the suspended coupons, and increased biomass was observed in isolates treated with clarithromycin. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:81 / 86
页数:6
相关论文
共 23 条
[1]   Regulation of Salmonella typhimurium virulence gene expression by cationic antimicrobial peptides [J].
Bader, MW ;
Navarre, WW ;
Shiau, W ;
Nikaido, H ;
Frye, JG ;
McClelland, M ;
Fang, FC ;
Miller, SI .
MOLECULAR MICROBIOLOGY, 2003, 50 (01) :219-230
[2]  
Clinical and Laboratory Standards Institute (CLSI), 2007, M100S17 CLSI
[3]   Bacterial biofilms: A common cause of persistent infections [J].
Costerton, JW ;
Stewart, PS ;
Greenberg, EP .
SCIENCE, 1999, 284 (5418) :1318-1322
[4]   Biofilm formation by Pseudomonas aeruginosa:: role of the C4-HSL cell-to-cell signal and inhibition by azithromycin [J].
Favre-Bonté, S ;
Köhler, T ;
Van Delden, C .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 52 (04) :598-604
[5]   Issue reparative effects of macrolide antibiotics in chronic inflammatory sinopulmonary diseases [J].
Garey, KW ;
Alwani, A ;
Danziger, LH ;
Rubinstein, I .
CHEST, 2003, 123 (01) :261-265
[6]   Azithromycin retards Pseudomonas aeruginosa Biofilm Formation [J].
Gillis, RJ ;
Iglewski, BH .
JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (12) :5842-5845
[7]   Transcriptional modulation of bacterial gene expression by subinhibitory concentrations of antibiotics [J].
Goh, EB ;
Yim, G ;
Tsui, W ;
McClure, J ;
Surette, MG ;
Davies, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (26) :17025-17030
[8]   How to optimize the drop plate method for enumerating bacteria [J].
Herigstad, B ;
Hamilton, M ;
Heersink, J .
JOURNAL OF MICROBIOLOGICAL METHODS, 2001, 44 (02) :121-129
[9]   Aminoglycoside antibiotics induce bacterial biofilm formation [J].
Hoffman, LR ;
D'Argenio, DA ;
MacCoss, MJ ;
Zhang, ZY ;
Jones, RA ;
Miller, SI .
NATURE, 2005, 436 (7054) :1171-1175
[10]   Azithromycin inhibits MUC5AC production induced by the Pseudomonas aeruginosa autoinducer N-(3-oxododecanoyl) homoserine lactone in NCI-H292 cells [J].
Imamura, Y ;
Yanagihara, K ;
Mizuta, Y ;
Seki, M ;
Ohno, H ;
Higashiyama, Y ;
Miyazaki, Y ;
Tsukamoto, K ;
Hirakata, Y ;
Tomono, K ;
Kadota, J ;
Kohno, S .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (09) :3457-3461